Biliary Tract Cancer Clinical Trials in Hanover
2 recruitingHanover, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 2
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
Biliary Tract CancerHER2HER2 Gene Mutation
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest24 enrolled7 locationsNCT06178445
Recruiting
Phase 2
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Colorectal, CancerGastric CancerBiliary Tract Cancer+4 more
AstraZeneca582 enrolled95 locationsNCT05489211